Literature DB >> 3003621

Familial amyloidotic polyneuropathy diagnosed by cloned human prealbumin cDNA.

S Mita, S Maeda, M Ide, T Tsuzuki, K Shimada, S Araki.   

Abstract

A diagnosis of familial amyloidotic polyneuropathy (FAP) can be made by use of restriction endonuclease NsiI, a cloned human prealbumin cDNA and Southern blot procedures. Digests of DNAs from 10 disease-free individuals showed two bands (6.6 kb and 3.2 kb) complementary to a human prealbumin cDNA, whereas digests from 11 individuals with FAP exhibited two additional bands (5.1 kb and 1.5 kb). We interpret these changes in pattern to be the result of a restriction site for NsiI located in the altered codon and associated with the mutant prealbumin gene. All these individuals with FAP were heterozygous for the prealbumin gene, carrying one normal and one mutant gene.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003621     DOI: 10.1212/wnl.36.2.298

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  "Sporadic" prealbumin-related amyloid polyneuropathy: report of two cases.

Authors:  M Yamada; H Tsukagoshi; J Satoh; S Ishiai; M Nakazato; H Furuya; H Sasaki; Y Sakaki; T Yokota
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

2.  Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val----Met mutation most common to the disease.

Authors:  K Yoshioka; H Furuya; H Sasaki; M J Saraiva; P P Costa; Y Sakaki
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

3.  Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I.

Authors:  Y Takaoka; F Tashiro; S Yi; S Maeda; K Shimada; K Takahashi; Y Sakaki; K Yamamura
Journal:  Transgenic Res       Date:  1997-07       Impact factor: 2.788

4.  Identification of carriers of mutant prealbumin gene associated with familial amyloidotic polyneuropathy type I by Southern blot procedures: study of six pedigrees in the Arao district of Japan.

Authors:  M Ide; S Mita; S Ikegawa; S Maeda; K Shimada; S Araki
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

5.  Ocular microangiopathy in familial amyloidotic polyneuropathy, type I.

Authors:  E Ando; Y Ando; S Maruoka; Y Sakai; S Watanabe; R Yamashita; R Okamura; S Araki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

6.  Familial amyloidotic polyneuropathy without familial occurrence: carrier detection by the radioimmunoassay of variant transthyretin.

Authors:  M Tanaka; S Hirai; E Matsubara; K Okamoto; M Morimatsu; M Nakazato
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

Review 7.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

8.  Molecular analysis of a variant type of familial amyloidotic polyneuropathy showing cerebellar ataxia and pyramidal tract signs.

Authors:  H Furuya; K Yoshioka; H Sasaki; Y Sakaki; M Nakazato; H Matsuo; A Nakadai; S Ikeda; N Yanagisawa
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

9.  Haemarthrosis due to fracture through amyloid deposits in bone in Portuguese familial amyloidosis.

Authors:  S A Allard; R H King; P K Thomas; B E Bourke
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

10.  Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy.

Authors:  T Murakami; S Yi; S Maeda; F Tashiro; K Yamamura; K Takahashi; K Shimada; S Araki
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.